This article provides a comprehensive guide for researchers, scientists, and drug development professionals on establishing a robust contamination control strategy (CCS) for cell therapy manufacturing.
Allogeneic cell therapies offer a scalable, 'off-the-shelf' alternative to autologous treatments but face significant barriers from host immune rejection and graft-versus-host disease (GvHD).
This article provides a comprehensive analysis of non-relapse mortality (NRM) following hematopoietic stem cell transplantation, contrasting the significantly higher risks associated with allogeneic (allo-SCT) versus autologous (auto-SCT) procedures.
This article provides a comprehensive analysis of the manufacturing processes for autologous and allogeneic cell therapies, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive analysis of cell expansion protocols for autologous and allogeneic therapies, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive overview of the application of Pharmacokinetic-Pharmacodynamic (PK-PD) correlation modeling in natural product research.
The glucose-stimulated insulin secretion (GSIS) assay is the gold-standard functional test for evaluating stem cell-derived beta (SC-beta) cells, crucial for diabetes research and therapy development.
This article provides a comprehensive guide for researchers and drug development professionals on isolating exosomes from Mesenchymal Stem Cell (MSC) conditioned media using ultracentrifugation.
This article provides a comprehensive guide for researchers and drug development professionals on establishing effective patient recruitment and clinical data collection frameworks for human induced pluripotent stem cell (hiPSC) studies.
This article provides a comprehensive guide to Process Performance Qualification (PPQ) for autologous cell therapies, addressing the unique challenges posed by patient-specific manufacturing.